ABC | Volume 112, Nº6, Junho 2019

Artigo Original Ding Significância clínica dos parâmetros plaquetários como VPM Arq Bras Cardiol. 2019; 112(6):715-719 1. Tomey M, Mehran R. Dual antiplatelet therapy dilemmas: duration and choice of antiplatelets in acute coronary syndromes. Curr Cardiol Rep. 2013;15(10):405. 2. Tjia J, Allison J, Saczynski JS, Tisminetzky M, Givens JL, Lapane K ,et al. Encouraging trends in acutemyocardial infarction survival in the oldest old. Am J Med. 2013;126(9):798-804. 3. Task ForceMembers, Montalescot G, SechtemU, Achenbach S, Andreotti F, Arden C, et al. 2013 ESC guidelines on the management of stable coronary artery disease. Eur Heart J. 2013;34(38):2949-3003. 4. Gawaz M. Role of platelets in coronary thrombosis and reperfusion of ischemic myocardium. Cardiovasc Res. 2004;61(3):498-511. 5. Larsen SB, Grove EL, Kristensen SD, Hvas AM. Reduced antiplatelet effect of aspirin is associated with low-grade inflammation in patients with coronary artery disease. Thromb Haemost. 2013;109(5):920-9. 6. Chu SG, Becker RC, Berger PB, Bhatt DL, Eikelboom JW, Konkle B, et al. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J Thromb Haemost. 2010;8(1):148-56. 7. Carda R, Aceña Á, Pello A, Cristóbal C, Tarín N, Huelmos A, et al. The prognostic value of high-sensitive troponin i in stable coronary artery disease depends on age and other clinical variables. Cardiology. 2015;132(1):1-8. 8. Liu SW, Qiao SB, Yuan JS, Liu DQ. Association of plasma visfatin levels with inflammation, atherosclerosis and acute coronary syndromes (ACS) in humans. Clin Endocrinol (Oxf). 2009;71(2):202-7. 9. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, et al. Markers of inflammation and cardiovascular disease application to clinical and public health practice: a statement for healthcare professionals from the centers for disease control and prevention and the AmericanHeart Association. Circulation. 2003;107(3):499-511. 10. CannonCP,McCabeCH,WilcoxRG,BentleyJH,BraunwaldE.Associationof whitebloodcellcountwith increasedmortality inacutemyocardial infarction and unstable angina pectoris. Am J Cardiol. 2001;87(5):636-9, A10. 11. Hong LF, Li XL, Luo SH, Guo YL, Liu J, Zhu CG. Relation of leukocytes and its subsets counts with the severity of stable coronary artery disease in patients with diabetic mellitus. PLoS One. 2014;9(3):e90663. 12. Azab B, Chainani V, Shah N, McGinn JT. Neutrophil–Lymphocyte ratio as a predictor of major adverse cardiac events among diabetic population a 4-year follow-up study. Angiology. 2013;64(6):456-65. 13. PapaA,EmdinM,PassinoC,MichelassiC,BattagliaD,CocciF.Predictivevalue of elevatedneutrophil–lymphocyteratiooncardiacmortality in patients with stable coronary artery disease. Clin ChimActa. 2008;395(1-2):27-31. 14. Ihara A, Kawamoto T, Matsumoto K, Shouno S, Hirahara C, Morimoto T, et al.Relationshipbetweenplatelet indexesandcoronaryangiographic findings in patients with ischemic heart disease. Pathophysiol Haemost Thromb. 2006;35(5):376-9. 15. Bae MH, Lee JH, Yang DH, Park HS, Cho Y, Chae SC. White blood cell, hemoglobin and platelet distribution width as short-term prognostic markers in patients with acute myocardial infarction. J Korean Med Sci. 2014;29(4):519-26. 16. Bath PM, Butterworth RJ. Platelet size: measurement, physiology and vascular disease. Blood Coagul Fibrinolysis. 1996;7(2):157-61. 17. Chu SG, Becker RC, Berger PB, Bhatt DL, Eikelboom JW, Konkle B, et al. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J Thromb Haemost. 2010;8(1):148-56. 18. Ranjith MP, DivyaRaj R, MathewD, George B, Krishnan MN. Mean platelet volume and cardiovascular outcomes in acutemyocardial infarction. Heart Asia. 2016;8(1):16-20. Referências Este é um artigo de acesso aberto distribuído sob os termos da licença de atribuição pelo Creative Commons Fontes de financiamento Opresente estudo não teve fontes de financiamento externas. Vinculação acadêmica Não há vinculação deste estudo a programas de pós‑graduação. Aprovação ética e consentimento informado Este estudo foi aprovado pelo Comitê de Ética do Jinshan Hospital, Fudan University sob o número de protocolo 785. Todos os procedimentos envolvidos nesse estudo estão de acordo com a Declaração de Helsinki de 1975, atualizada em 2013. O consentimento informado foi obtido de todos os participantes incluídos no estudo. 719